Partnership with Boehringer Ingelheim for a medical trial on schizophrenia
Happyneuron to provide a Computerized Cognitive Training program for a large clinical trial by Boehringer Ingelheim investigating combined schizophrenia therapy Happyneuron SAS, a subsidiary of SBT Human(s) Matter Group, announces that it has been chosen by Boehringer Ingelheim, one of the pharmaceutical industry’s top 20 companies, to provide the at-home computerized cognitive training (CCT) […]